Financials
Financial year 2025
Gross margin
€ 1.9 million
▲ 105% vs 2024
Profit
Growing€ 1.3 million
▲ 111% vs 2024
Debts
Low€ 2.2 million
▼ 70% vs 2024
CoreAalst from Aalst, company number BE0755485389, closed financial year 2025 with a result of € 1.3 million after tax. For that financial year CoreAalst recorded a gross margin of € 1.9 million and equity of € 2 million. Compared with financial year 2024, the result moved from € 592,608 to € 1.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
What happened at CoreAalst?
What happened at CoreAalst in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.3 million (▲ 111% vs 2024). Source: NBB ↗
- Carlos Collet Bortone stepped down as director. NBB
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
- Carlos Collet Bortone became a director. NBB
In short
From € 177,675 profit in 2021 to € 1.3 million profit in 2025.
Paid € 783,725 in corporate taxes since 2021.
Best year ever: 2025, with € 1.3 million profit.
On average € 1.1 million of value added per employee in 2025.
A new publication or filing at CoreAalst? We notify you, reason included.
Follow CoreAalstNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CoreAalst are Nicolas Foin, Jozef Bartunek, Tom De Potter, Jeroen Sonck, Ward Heggermont and Johannes Brons. The same people are also behind Cardiovascular Research Center Aalst, CARDIAC RESEARCH INSTITUTE, DICENTRA, ARTERIAX and Dr. W. Heggermont, cardiologie.
Directors
According to the 2025 annual accounts
Nicolas Foin
Director
Jozef Bartunek
Director
Also active at: Cardiovascular Research Center Aalst, CARDIAC RESEARCH INSTITUTE, DICENTRA
Tom De Potter
Director
Ward Heggermont
Director
Also active at: Cardiovascular Research Center Aalst, CARDIAC RESEARCH INSTITUTE, Dr. W. Heggermont, cardiologie
Johannes Brons
Director
since 2020 · until 2025
Establishments
Establishment units
Physical locations of this company
Capucienenlaan 93A
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0755.485.389
- VAT number
- BE 0755.485.389
- Registered office
- Capucienenlaan 93A, 9300 Aalst
- Names & denominations
- CoreAalst
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 October 2020
- Peppol
- Active · Active since 9 Jan 2026
- Contact
- info@coreaalst.com
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige dienstverlenende activiteiten op het gebied van informatie
Gegevensverwerking, webhosting en aanverwante activiteiten
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.
Overige gespecialiseerde wetenschappelijke en technische activiteiten